"Hepatitis C" - Books

Result Filters

See c curved in the Gene database

c in Drosophila melanogaster Hepatitis B virus Respirovirus muris All 67 Gene records

Results: 1 to 20 of 1205 books (8717 items)

<< First< Prev

Page of 61

Next >Last >>

Select item 44036681.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

Top results in this book Table of Contents

Select item 44277682.

WHO Guidelines on Hepatitis B and C Testing.

Geneva: World Health Organization; 2017 Feb.

Top results in this book Table of Contents

Select item 42521043.

Direct-Acting Antiviral Agents for Chronic Hepatitis C Genotype 1 [Internet].

Murphy G, Farah B, Wong W, et al.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Oct. (CADTH Therapeutic Review, No. 2.2B.)

Top results in this book Table of Contents

Select item 48538164.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 26591825.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 46301066.

Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection [Internet].

Geneva: World Health Organization; 2018 Jul.

Top results in this book Table of Contents

Select item 43678027.

Simeprevir (Galexos) (150 mg) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.

Top results in this book Table of Contents

Select item 42365288.

Drugs for Chronic Hepatitis C Infection: Clinical Review [Internet].

Wells G, Kelly S, Farah B, et al.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Jan. (CADTH Therapeutic Review, No. 3.1B.)

Top results in this book Table of Contents

Select item 14003629.

Hepatitis C Viruses: Genomes and Molecular Biology.

Tan SL, editor.

Norfolk (UK): Horizon Bioscience; 2006.

Top results in this book Table of Contents

Select item 330816810.

Sofosbuvir (Sovaldi): Sofosbuvir is Indicated for the Treatment of Chronic Hepatitis C Virus (CHC) Infection in Adult Patients With Compensated Liver Disease, Including Cirrhosis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Oct.

Top results in this book Table of Contents

Select item 426180211.

Ledipasvir/Sofosbuvir (Harvoni): For the Treatment of Chronic Hepatitis C Virus (CHC) G1 Infection in Adults [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.

Top results in this book Table of Contents

Select item 426099812.

Eltrombopag Olamine (Revolade) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug.

Top results in this book Table of Contents

Select item 303945613.

Guidance on Prevention of Viral Hepatitis B and C Among People Who Inject Drugs.

Geneva: World Health Organization; 2012 Jul.

Top results in this book Table of Contents

Select item 423684214.

Drugs for Chronic Hepatitis C Infection: Cost-Effectiveness Analysis [Internet].

Wong W, Krahn M, Lee K, et al.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Jan. (CADTH Therapeutic Review, No. 3.1C.)

Top results in this book Table of Contents

Select item 442754615.

A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on a National Strategy for the Elimination of Hepatitis B and C; Strom BL, Buckley GJ, editors.

Washington (DC): National Academies Press (US); 2017 Mar 28.

Top results in this book Table of Contents

Select item 300197216.

Treatment for Hepatitis C Virus Infection in Adults [Internet].

Chou R, Hartung D, Rahman B, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov. (Comparative Effectiveness Reviews, No. 76.)

Top results in this book Table of Contents

Select item 547163217.

Updated Recommendations on Treatment of Adolescents and Children with Chronic HCV Infection, and HCV Simplified Service Delivery and Diagnostics [Internet].

Geneva: World Health Organization; 2022.

Top results in this book Table of Contents

Select item 508103418.

PEP to Prevent HIV Infection [Internet].

Cowan E, Marks K, Daniel J, et al.

Baltimore (MD): Johns Hopkins University; 2025 Dec.

Top results in this book Table of Contents

Select item 466065419.

Clinical Review Report: Glecaprevir / Pibrentasvir (Maviret): (AbbVie Corporation): Indication: Hepatitis C genotype 1 to 6 [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Feb.

Top results in this book Table of Contents

Select item 458224020.

Hepatitis Viruses.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 1994. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 59.)

Top results in this book Table of Contents

<< First< Prev

Page of 61

Next >Last >>

Supplemental Content

Images search in Bookshelf

FIGURE 3-1The treatment cascade for chronic hepatitis C virus infection in the United States

NOTE: HCV, hepatitis C virus; RNA, ribonucleic acid; SVR, sustained virologic response; VA, Department of Veterans Affairs.
SOURCE: Yehia et al., 2014.

The Elimination of Hepatitis C.

Committee on a National Strategy for the Elimination of Hepatitis B and C; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine; Buckley GJ, Strom BL, editors. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington (DC): National Academies Press (US); 2016 Jun 1.
Fig. 1.

Genomic structure, processed products and antigen epitopes of hepatitis C virus

HEPATITIS C VIRUS.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Hepatitis Viruses. Lyon (FR): International Agency for Research on Cancer; 1994.
Figure 2Rate of inpatient stays involving hepatitis C by patient age group, 2005–2014

Note: All stays involving hepatitis C are included—those stays with and without hepatitis B, human immunodeficiency virus (HIV), and alcoholic liver disease.
Source: Agency for Healthcare Research and Quality (AHRQ), Center for Delivery, Organization, and Markets, Healthcare Cost and Utilization Project (HCUP), National (Nationwide) Inpatient Sample (NIS), 2005–2014

Characteristics of Inpatient Stays Involving Hepatitis C, 2005–2014.

Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-.
Figure 31Pooled proportions of mortality for treatment-experienced hepatitis C genotype 3

Systematic review and network meta-analysis to support the development of the WHO guidelines for the screening, care and treatment of persons with chronic hepatitis C infection.

Guidelines for the Screening Care and Treatment of Persons with Chronic Hepatitis C Infection: Updated Version. Geneva: World Health Organization; 2016 Apr.